Dr Dave Mentlak

Senior Scientist at Mesenbio

Speaker

As a Senior Scientist at Mesenbio, Dave is at the forefront of developing MEV-N01, an innovative regenerative therapy for arthritic diseases. With over eight years bridging the gap between academic research and industry application, Dave has a track record of enhancing therapeutic antibody production in Chinese Hamster Ovary (CHO) cells, working in tandem with entities like Fujifilm Diosynth Biotechnologies and the University of York. His experience encompasses critical aspects of biologics production, such as cell growth, yield and product quality improvement. At Mesenbio, Dave utilises his extensive background in cell biology and bioprocessing knowledge to propel the development of therapeutic EVs, contributing to the company’s cutting-edge solutions in regenerative medicine